These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 2894175

  • 1. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K, Fox IL, Greenblatt DJ, Sandler KR, Schless A.
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF, Putman HP.
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Review of the side-effect profile of buspirone.
    Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ.
    Am J Med; 1986 Mar 31; 80(3B):17-21. PubMed ID: 2870641
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC, O'Hair DE.
    Clin Ther; 1980 Mar 31; 3(3):209-18. PubMed ID: 6109568
    [Abstract] [Full Text] [Related]

  • 11. Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
    Mielke DH, Gallant DM, McFarlain RA.
    Curr Ther Res Clin Exp; 1976 May 31; 19(5):506-11. PubMed ID: 7433
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P, Rouillon F, Pouget D.
    Encephale; 1996 May 31; 22(6):461-7. PubMed ID: 10901839
    [Abstract] [Full Text] [Related]

  • 13. Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
    Mandos LA, Rickels K, Cutler N, Roeschen J, Keppel Hesselink JM, Schweizer E.
    Int Clin Psychopharmacol; 1995 Nov 31; 10(4):251-6. PubMed ID: 8748047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG.
    J Clin Psychiatry; 1978 Oct 31; 39(10 Pt 2):24-9. PubMed ID: 30763
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984 Oct 31; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 20. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG.
    Curr Ther Res Clin Exp; 1975 Jan 31; 17(1):13-22. PubMed ID: 237741
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.